151 related articles for article (PubMed ID: 21421185)
1. Effects of local intracoronary paclitaxel delivery using the Remedy transport catheter on neointimal hyperplasia after stent implantation in a porcine model.
Milewski K; Zurakowski A; Pajak J; Liszka L; Debinski M; Buszman PP; Samra MA; Dominek P; Aboodi MS; Kaluza GL; Buszman P
Cardiovasc Revasc Med; 2011; 12(2):82-9. PubMed ID: 21421185
[TBL] [Abstract][Full Text] [Related]
2. Differences in vessel healing following delivery of everolimus or paclitaxel: a comparative experimental study using identical stent and biodegradable polymer platforms.
Buszman PP; Milewski K; Pająk J; Jelonek M; Orlik B; Krauze A; Gwiazdowska-Nowotka B; Wojakowski W; Tellez A; Granada JF; Buszman PE
EuroIntervention; 2014 Oct; 10(6):724-31. PubMed ID: 24469344
[TBL] [Abstract][Full Text] [Related]
3. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.
Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR
Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536
[TBL] [Abstract][Full Text] [Related]
4. Biological effect on drug distribution and vascular healing via paclitaxel-coated balloon technology in drug eluting stent restenosis swine model.
Li Y; Tellez A; Rousselle SD; Dillon KN; Garza JA; Barry C; Granada JF
Catheter Cardiovasc Interv; 2016 Jul; 88(1):89-98. PubMed ID: 26613810
[TBL] [Abstract][Full Text] [Related]
5. Novel biodegradable polymer-coated, paclitaxel-eluting stent inhibits neointimal formation in porcine coronary arteries.
Buszman P; Milewski K; Zurakowski A; Pajak J; Liszka Ł; Buszman P; Musioł E; AbuSamra M; Trznadel S; Kałuza G
Kardiol Pol; 2010 May; 68(5):503-9. PubMed ID: 20491008
[TBL] [Abstract][Full Text] [Related]
6. The effect of shear stress on neointimal response following sirolimus- and paclitaxel-eluting stent implantation compared with bare-metal stents in humans.
Papafaklis MI; Bourantas CV; Theodorakis PE; Katsouras CS; Naka KK; Fotiadis DI; Michalis LK
JACC Cardiovasc Interv; 2010 Nov; 3(11):1181-9. PubMed ID: 21087755
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects on vascular healing of bare metal stents delivered via paclitaxel-coated balloons in the porcine model of restenosis.
Cremers B; Milewski K; Clever YP; Aboodi MS; Biedermann M; Thim T; Kelsch B; Kaluza GL; Scheller B; Granada JF
Catheter Cardiovasc Interv; 2012 Oct; 80(4):603-10. PubMed ID: 22511557
[TBL] [Abstract][Full Text] [Related]
8. Cutting balloon combined with paclitaxel-eluting balloon for treatment of in-stent restenosis.
Kong J; Hou J; Ma L; Xing L; Jia H; Liu H; Zhang S; Yu B; Jang IK
Arch Cardiovasc Dis; 2013 Feb; 106(2):79-85. PubMed ID: 23527911
[TBL] [Abstract][Full Text] [Related]
9. Novel Sirolimus-Coated Balloon Catheter: In Vivo Evaluation in a Porcine Coronary Model.
Clever YP; Peters D; Calisse J; Bettink S; Berg MC; Sperling C; Stoever M; Cremers B; Kelsch B; Böhm M; Speck U; Scheller B
Circ Cardiovasc Interv; 2016 Apr; 9(4):e003543. PubMed ID: 27069105
[TBL] [Abstract][Full Text] [Related]
10. Intravascular ultrasound results from the ENDEAVOR IV trial: randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease.
Waseda K; Miyazawa A; Ako J; Hasegawa T; Tsujino I; Sakurai R; Yock PG; Honda Y; Kandzari DE; Leon MB; Fitzgerald PJ;
JACC Cardiovasc Interv; 2009 Aug; 2(8):779-84. PubMed ID: 19695548
[TBL] [Abstract][Full Text] [Related]
11. Comparison of short- and long-term results of drug-eluting vs. bare metal stenting in the porcine internal carotid artery.
Schwarzmaier-D'Assie A; Nyolczas N; Hemetsberger R; Strehblow C; Matiasek J; Farhan S; Petrasi Z; Huber K; Wojta J; Glogar D; Plass C; Gyöngyösi M; Karnik R
J Endovasc Ther; 2011 Aug; 18(4):547-58. PubMed ID: 21861747
[TBL] [Abstract][Full Text] [Related]
12. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).
Valgimigli M; Tebaldi M; Borghesi M; Vranckx P; Campo G; Tumscitz C; Cangiano E; Minarelli M; Scalone A; Cavazza C; Marchesini J; Parrinello G;
JACC Cardiovasc Interv; 2014 Jan; 7(1):20-8. PubMed ID: 24332420
[TBL] [Abstract][Full Text] [Related]
13. Impact of Fluoropolymer-Based Paclitaxel Delivery on Neointimal Proliferation and Vascular Healing: A Comparative Peripheral Drug-Eluting Stent Study in the Familial Hypercholesterolemic Swine Model of Femoral Restenosis.
Gasior P; Cheng Y; Valencia AF; McGregor J; Conditt GB; Kaluza GL; Granada JF
Circ Cardiovasc Interv; 2017 May; 10(5):. PubMed ID: 28487355
[TBL] [Abstract][Full Text] [Related]
14. A head to head comparison of XINSORB bioresorbable sirolimus-eluting scaffold versus metallic sirolimus-eluting stent: 180 days follow-up in a porcine model.
Shen L; Wu Y; Ge L; Zhang Y; Wang Q; Qian J; Qiu Z; Ge J
Int J Cardiovasc Imaging; 2017 Oct; 33(10):1473-1481. PubMed ID: 28639098
[TBL] [Abstract][Full Text] [Related]
15. Stent healing response following delivery of paclitaxel via durable polymeric matrix versus iopromide-based balloon coating in the familial hypercholesterolaemic swine model of coronary injury.
Buszman PP; Tellez A; Afari M; Cheng Y; Conditt GB; McGregor JC; Milewski K; Stenoien M; Kaluza GL; Granada JF
EuroIntervention; 2013 Aug; 9(4):510-6. PubMed ID: 23965356
[TBL] [Abstract][Full Text] [Related]
16. Local paclitaxel delivery after coronary stenting in an experimental animal model.
Dommke C; Haase KK; Süselbeck T; Streitner I; Haghi D; Metz J; Borggrefe M; Herdeg C
Thromb Haemost; 2007 Sep; 98(3):674-80. PubMed ID: 17849059
[TBL] [Abstract][Full Text] [Related]
17. Comparison of vascular response to the everolimus-eluting stent versus the paclitaxel-eluting stent: intravascular ultrasound results from the SPIRIT III trial.
Yamasaki M; Tsujino I; Lima-Filho MO; Ako J; Shimohama T; Hasegawa T; Sakurai R; Sudhir K; Stone GW; Waseda K; Honda Y; Fitzgerald PJ
EuroIntervention; 2012 Oct; 8(6):724-31. PubMed ID: 23086791
[TBL] [Abstract][Full Text] [Related]
18. Solely abluminal drug release from coronary stents could possibly improve reendothelialization.
Zhang H; Deng W; Wang X; Wang S; Ge J; Toft E
Catheter Cardiovasc Interv; 2016 Sep; 88(3):E59-66. PubMed ID: 24323634
[TBL] [Abstract][Full Text] [Related]
19. Influence of a paclitaxel coated balloon in combination with a bare metal stent on restenosis and endothelial function: comparison with a drug eluting stent and a bare metal stent.
Clever YP; Cremers B; Speck U; Dietz U; Böhm M; Scheller B
Catheter Cardiovasc Interv; 2014 Aug; 84(2):323-31. PubMed ID: 23996969
[TBL] [Abstract][Full Text] [Related]
20. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW
JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]